[1]
Mahmoud Essam et al. 2023. Lack of HBV reactivation among patients receiving immunomodulatory drugs in Egyptian cohort who underwent either close monitoring or Preemptive treatment. Journal of Population Therapeutics and Clinical Pharmacology. 30, 4 (Mar. 2023), 123–130. DOI:https://doi.org/10.47750/jptcp.2023.30.04.012.